Suchergebnisse - "Pala, Daniele"

PubPharm (6)

1

Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension

enthalten in: European journal of pharmacology | 2019

von Cantoni, S. | Cavalli, S. | Pastore, F. | +8

2

Atropisomerism and Conformational Equilibria : Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs

enthalten in: Journal of medicinal chemistry | 2017

von Lodola, A. | Bertolini, S. | Biagetti, M. | +10

3

Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8

enthalten in: Journal of chemical information and modeling | 2017

von Callegari, D. | Lodola, A. | Pala, D. | +4

ErratumIn: J Chem Inf Model. 2017 Feb 27;57(2):386. - PMID 28151658

4

Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis

enthalten in: Biochemical pharmacology | 2016

von Giorgio, C. | Russo, S. | Incerti, M. | +10

5

Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists

enthalten in: Molecules (Basel, Switzerland) | 2015

von Callegari, D. | Pala, D. | Scalvini, L. | +5

6

Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction

enthalten in: Journal of chemical information and modeling | 2014

von Pala, D. | Castelli, R. | Incerti, M. | +9

1
[1]